BNP Paribas Financial Markets’s DiaMedica Therapeutics DMAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.6K | Buy |
18,882
+3,709
| +24% | +$14.5K | ﹤0.01% | 3308 |
|
|
2025
Q1 | $57.5K | Sell |
15,173
-1,627
| -10% | -$6.17K | ﹤0.01% | 3412 |
|
|
2024
Q4 | $91.2K | Buy |
16,800
+300
| +2% | +$1.63K | ﹤0.01% | 3340 |
|
|
2024
Q3 | $69.1K | Buy |
16,500
+1,300
| +9% | +$5.45K | ﹤0.01% | 2822 |
|
|
2024
Q2 | $44.8K | Buy |
15,200
+700
| +5% | +$2.07K | ﹤0.01% | 2794 |
|
|
2024
Q1 | $40.2K | Buy |
14,500
+500
| +4% | +$1.39K | ﹤0.01% | 2927 |
|
|
2023
Q4 | $39.8K | Hold |
14,000
| – | – | ﹤0.01% | 2888 |
|
|
2023
Q3 | $36.1K | Buy |
14,000
+4,200
| +43% | +$10.8K | ﹤0.01% | 2829 |
|
|
2023
Q2 | $42.3K | Buy |
9,800
+7,596
| +345% | +$32.8K | ﹤0.01% | 2891 |
|
|
2023
Q1 | $3.37K | Buy |
2,204
+1,604
| +267% | +$2.45K | ﹤0.01% | 2976 |
|
|
2022
Q4 | $948 | Buy |
+600
| New | +$948 | ﹤0.01% | 3145 |
|